Key Pharmaceuticals Limited
Sham Mathdevru has a Master's degree in Formulation Science from the University of Greenwich. From February 2010 to July 2011, worked as a Quality Associate at Bristol Laboratories Ltd. From July 2011 to June 2016, held the position of Scientific Officer at Napp Pharmaceuticals Limited. Currently, since June 2016, works as the Head Of Operations at KEY PHARMACEUTICALS LIMITED/Redgrove Pharmaceuticals Ltd, overseeing regulatory affairs, quality assurance, project management, HR, and admin. Additionally, serves as the Regulatory Affairs Manager, providing leadership for EU regulatory submissions teams to obtain and maintain marketing authorizations for products in designated territories.
This person is not in any teams
Key Pharmaceuticals Limited
Based in Cambridgeshire, UK, with additional offices in Dublin and Pune, Key Pharmaceuticals has been involved in the development, manufacture and regulatory support of generic pharmaceuticals for 20 years. Through our technical knowledge and regulatory expertise, we have successfully developed, registered and launched 22 generic drugs in the UK, with many more in the pipeline. These products are now being prescribed across the country and delivered through our wide distribution network. Our products are used in hospitals, clinics and pharmacies up and down the UK. Through our product and regulatory experience, we are able to provide full support across the product lifecycle to those who require it. Across formulation, development, clinical, manufacturing scale up, registration, ongoing pharmacovigilance support, we will provide you a one stop shop to manage all of these elements. Key Pharmaceuticals is proud to be part of the Lexon Group, which has extensive wholesaling and retail operations within the UK, giving us an unparalleled level of support in serving the UK market. The extremely high quality of our medicines, which are developed and manufactured to the UK Medicines and Healthcare products Regulatory Agency (MHRA) GMP standards, has not gone un-noticed. International demand has been growing at a rapid pace, and our products are now available in markets across all 6 continents. With Marketing Authorisations granted by the MHRA and Certificate of Pharmaceutical Product (CPP) available, we are a natural fit for companies in both highly regulated and unregulated markets to expand their portfolio.